Oncology & Cancer

Nanosensor that lights up cancer to be tested in surgeries

UT Southwestern Simmons Cancer Center scientists next month will begin testing a digital nanosensor that lights up cancer tissue to see whether it can improve the accuracy of cancer surgeries, thereby reducing cancer recurrence ...

Oncology & Cancer

Neoadjuvant immunotherapy improves outlook in high-risk melanoma

Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who ...

Oncology & Cancer

Research is changing the game for melanoma treatment

Wilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist and published in The ...

page 10 from 40